Skip to main content

DEVELOPMENT AND EVALUATION OF NANOMEDICINES

TEC2022-012

DEVELOPMENT AND EVALUATION OF NANOMEDICINES

Healthcare technology, precision medicine and aging area

Objectives and lines of research

– Develop new nanosystems for drug encapsulation and study their interaction with the biological environment to optimize their therapeutic application.
– Development of nanotechnology-based strategies targeting the intestinal barrier.
– Characterization of the interaction of nanomedicines with biological barriers.
– Development of new nanomedicines for the treatment of ulcerative colitis

Research team

  • MARIA VICTORIA LOZANO LOPEZ
  • MARIA FRANCISCA GALINDO ANAYA
  • MANUEL JESÚS SANTANDER ORTEGA
  • JOAQUÍN GONZÁLEZ FUENTES

Responsible

MARIA VICTORIA LOZANO LOPEZ

IP

MARIA VICTORIA LOZANO LOPEZ